scholarly journals Standard endovascular aneurysm repair in patients with wide infrarenal aneurysm necks is associated with increased risk of adverse events

2017 ◽  
Vol 65 (6) ◽  
pp. 1608-1616 ◽  
Author(s):  
Nelson F.G. Oliveira ◽  
Frederico M. Bastos Gonçalves ◽  
Marie Josee Van Rijn ◽  
Quirina de Ruiter ◽  
Sanne Hoeks ◽  
...  
2016 ◽  
Vol 63 (6) ◽  
pp. 146S
Author(s):  
Nelson Gomes Oliveira ◽  
Frederico Bastos Gonçalves ◽  
Quirina de Ruiter ◽  
Richte Schuurman ◽  
Frans Moll ◽  
...  

VASA ◽  
2018 ◽  
Vol 47 (4) ◽  
pp. 273-277
Author(s):  
Christopher Lowe ◽  
Oussama El Bakbachi ◽  
Damian Kelleher ◽  
Imran Asghar ◽  
Francesco Torella ◽  
...  

Abstract. The aim of this review was to investigate presentation, aetiology, management, and outcomes of bowel ischaemia following EVAR. We present a case report and searched electronic bibliographic databases to identify published reports of bowel ischaemia following elective infra-renal EVAR not involving hypogastric artery coverage or iliac branch devices. We conducted our review according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement standards. In total, five cohort studies and three case reports were included. These studies detailed some 6,184 infra-renal elective EVARs, without procedure-related occlusion of the hypogastric arteries, performed between 1996 and 2014. Bowel ischaemia in this setting is uncommon with an incidence ranging from 0.5 to 2.8 % and includes a spectrum of severity from mucosal to transmural ischaemia. Due to varying reporting standards, an overall proportion of patients requiring bowel resection could not be ascertained. In the larger series, mortality ranged from 35 to 80 %. Atheroembolization, hypotension, and inferior mesenteric artery occlusion were reported as potential causative factors. Elderly patients and those undergoing prolonged procedures appear at higher risk. Bowel ischaemia is a rare but potentially devastating complication following elective infra-renal EVAR and can occur in the setting of patent mesenteric vessels and hypogastric arteries. Mortality ranges from 35 to 80 %. Further research is required to identify risk factors and establish prophylactic measures in patients that have an increased risk of developing bowel ischaemia after standard infra-renal EVAR.


Author(s):  
David Octeau ◽  
Christopher Faries ◽  
Hanna Barnes ◽  
Kenneth R. Nakazawa ◽  
Ajit J. Rao ◽  
...  

2021 ◽  
Vol 74 (4) ◽  
pp. e355-e356
Author(s):  
Jordan Stoecker ◽  
Kevin Eddinger ◽  
Gina Biagetti ◽  
Alexander Fairman ◽  
Alison Pouch ◽  
...  

2020 ◽  
Vol 25 (44) ◽  
pp. 4675-4685 ◽  
Author(s):  
Petroula Nana ◽  
George Kouvelos ◽  
Alexandros Brotis ◽  
Konstantinos Spanos ◽  
Athanasios Giannoukas ◽  
...  

Aim: The effect of endovascular aneurysm repair in patients treated for abdominal aortic aneurysm has not been clearly defined. The objective of the present article was to provide a contemporary literature review and perform an analysis to determine the effect of EVAR on renal function in the early post-operative period and during follow-up. Methods: A systematic review of the literature was undertaken to identify all studies reporting the effect of EVAR on renal function. Outcome data were pooled and combined overall effect sizes were calculated using fixed or random-effects models. Results: Thirty-two studies reporting on 24846 patients were included. Acute renal failure after EVAR occurred with an estimated frequency of 9% (95%CI: 5-16%; I2=97%). Median follow-up period was 19.5 months (range 1-60 months). The estimated frequency of chronic renal failure during follow-up was 7% (95%CI: 3-17%; I2=98%). Hemodialysis was required in 2% (1-3%; I2=97%) of the cases. Conclusion: High-level evidence demonstrating the effect of EVAR on the incidence of acute and chronic renal failure is lacking. Based on the current available data, nearly 10% of patients undergoing EVAR for AAA have an increased risk for renal dysfunction after the procedure. Whether this deterioration may lead to a worse outcome has not been adequately proved.


2018 ◽  
Vol 67 (1) ◽  
pp. 126-133 ◽  
Author(s):  
Christine R. Herman ◽  
Philippe Charbonneau ◽  
Kiattisak Hongku ◽  
Luc Dubois ◽  
Sajjid Hossain ◽  
...  

2017 ◽  
Vol 22 (4) ◽  
pp. 316-323 ◽  
Author(s):  
Ikram-Ul Haq ◽  
Arun Kelay ◽  
Meryl Davis ◽  
Jocelyn Brookes ◽  
Tara M Mastracci ◽  
...  

Our objective was to determine the relative merits of intervention or observation of type II endoleaks (T2Ls). A retrospective analysis was performed on 386 infra-renal endovascular aneurysm repair (IR-EVAR) patients from 2006 to 2015. Annual surveillance imaging of patients undergoing EVAR at our centre were analysed, and all endoleaks were subjected to a multidisciplinary team meeting for consideration and treatment. In the 10-year time frame, 386 patients (79.5±8.7 years) underwent an IR-EVAR. Eighty-one patients (21.0%) developed a T2L and intervention was undertaken in 28 (34.6%): 17 (60.7%) were treated via a transarterial approach (TA) and 11 (39.3%) using the translumbar approach (TL). Fifty-three patients (65.4%) with T2Ls were managed conservatively. Patients who received T2L treatment had a greater proportion of recurrent T2Ls than patients who were conservatively managed ( p=0.032). T2Ls associated with aneurysmal growth were more resistant to treatment than those where there was no change or a decrease in aneurysm size during follow-up (0.033). There was no significant difference in the TA and TL approach with respect to endoleak repair success ( p=0.525). Treatment of a T2L did not confer a survival advantage compared to conservative management ( p=0.449) nor did the choice of either the TA or TL approach ( p=0.148). Our study suggests the development of a T2L associated with aneurysm growth may represent an aggressive phenotype that is resistant to treatment. However, this did not lead to an increased risk of mortality over follow-up. Neither a transarterial nor a translumbar approach to treating a T2L conferred superiority.


Sign in / Sign up

Export Citation Format

Share Document